Click here for corporate deck INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street, this is Juan Costello, Senior analyst with the Wall Street Analyzer. Joining us today is Michael Jennings CEO for Next Green Wave […]
Key products to be tested, registered and marketed include Insugin for diabetes application, alternative insulin for Alzheimer’s application, and Blood Plasma Derived Products, Human Serum Albumin 20% […]
Generex Biotechnology Corporation is an integrated healthcare holding company with end‐to‐end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. […]
Interview with COO Bill Abajian […]
Expansion to include increased royalties and cover additional applications for Company’s technology platform […]
Interview update with CEO Miriam Tuerk […]
WEST CALDWELL, NJ and TORONTO, ON, Sept. 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery […]
VANCOUVER, British Columbia, Aug. 27, 2019 (GLOBE NEWSWIRE) — Scottie Resources Corp. (“Scottie” or the “Company”) (TSXV: SCOT) is excited to share preliminary field observations from the current season’s exploration program on its Scottie Gold […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com